Literature DB >> 6779693

Electrocochleography and auditory brainstem electric responses in patients with pontine angle tumors.

J J Eggermont, M Don, D E Brackmann.   

Abstract

In 45 patients with surgically proven pontine angle tumors, compound action potential (AP) and summating potential (SP) were recorded with transtympanic electrocochleography (ECochG) together with brainstem electric responses (BSER). The aims were to quantify the mechanism by which tumors cause hearing loss and evaluate the diagnostic potentials of ECochG and BSER for detecting eighth nerve and brainstem tumors. Except for AP latency and narrow band AP waveform, response parameters recorded by ECochG are uncorrelated. Four uncorrelated parameters were abnormal in only 10% of the cases, three in 25%, two in 40%, and one in 90%. The BSER criterion was the latency delay between waves I and IV and resulted in about 90% detection, improving to 95% when used in combination with ther interaural wave V delay criterion. ECochG results provide evidence that, for hearing losses up to 60 dB HL, the origin is cochlear, resembling that caused by Meniere's disease. Evidence is presented that the increase in I-V delay in the BSERs is caused by differential action of the tumor upon low and high frequency fibers in the auditory nerve and that desynchronization of the firings of the nerve fibers is of more importance than an increase in neural conduction time. ECochG as the sole test for detection of pontine angle tumors appears to be of limited value. Brainstem response on its own has great merits; however, it should be emphasized that no wave I was detected in about 30% of the cases. The 95% detection score obtained with BSER depends on specifying the latency of wave I. For these cases, we substituted the latency of the AP recorded by ECochG.

Entities:  

Mesh:

Year:  1980        PMID: 6779693     DOI: 10.1177/00034894800890s601

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  11 in total

1.  False-negative brainstem auditory evoked potential recordings in a case of multiple acoustic neuroma.

Authors:  U W Buettner; A Thron; S Elies; E Grote
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

2.  Intra-operative electrocochleography to monitor cochlear potentials during acoustic neuroma excision.

Authors:  H I Sabin; P Bentivoglio; L Symon; A D Cheesman; D Prasher; F Momma
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 3.  Evoked potentials and brain stem reflexes.

Authors:  N Klug; G S Csécsei
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

Review 4.  Current audiological diagnostics.

Authors:  Sebastian Hoth; Izet Baljić
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

5.  Simultaneous recordings of human auditory potentials: transtympanic electrocochleography (ECoG) and brainstem-evoked responses (BER).

Authors:  M C Gersdorff
Journal:  Arch Otorhinolaryngol       Date:  1982

6.  Prognostic factors for postsurgical hearing and facial nerve function in cases of cerebellopontine angle-tumours. The meaning of brain stem evoked response audiometry (BERA).

Authors:  T Lenarz; W Sachsenheimer
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

7.  The application of evoked potentials in the diagnosis and follow-up of children with intracranial tumors.

Authors:  J J Rotteveel; E J Colon; G Hombergen; G B Stoelinga; R Lippens
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

8.  Auditory brain-stem response and hearing threshold in cerebellopontine angle tumours.

Authors:  S Prosser; E Arslan; A Pastore
Journal:  Arch Otorhinolaryngol       Date:  1984

Review 9.  Ups and Downs in 75 Years of Electrocochleography.

Authors:  Jos J Eggermont
Journal:  Front Syst Neurosci       Date:  2017-01-24

10.  Effects of Stimulus Intensity on Low-Frequency Toneburst Cochlear Microphonic Waveforms.

Authors:  Ming Zhang
Journal:  Audiol Res       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.